Trevena to Report Third Quarter 2017 Financial Results on November 7, 2017

Nov 01, 2017 7:00am EDT

Trevena Announces Publication and Presentations of OLINVO™ (oliceridine injection) Clinical Data

Oct 25, 2017 4:01pm EDT

Trevena Announces Restructuring to Focus Resources on Commercial Strategy

Oct 11, 2017 4:01pm EDT

Trevena To Present at the Ladenburg Thalmann 3rd Annual 2017 Healthcare Conference

Sep 22, 2017 2:09pm EDT

Trevena Announces Presentations during PAINWeek® 2017

Sep 07, 2017 4:01pm EDT

Trevena to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Sep 05, 2017 4:01pm EDT

Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Aug 31, 2017 4:01pm EDT

Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Aug 14, 2017 4:01pm EDT

Trevena Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Aug 03, 2017 7:00am EDT

Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jul 21, 2017 4:01pm EDT